AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,731,000 | -17.8% | 494,917 | -61.0% | 0.28% | -41.5% |
| Q3 2016 | $9,401,000 | +55.9% | 1,270,437 | +15.0% | 0.48% | +41.7% |
| Q2 2016 | $6,032,000 | -65.2% | 1,104,827 | -46.2% | 0.34% | -65.3% |
| Q1 2016 | $17,350,000 | -9.0% | 2,053,225 | +4.5% | 0.98% | -3.2% |
| Q4 2015 | $19,066,000 | +31.8% | 1,965,578 | +90.1% | 1.01% | +6.3% |
| Q3 2015 | $14,467,000 | +28.8% | 1,034,084 | +30.3% | 0.95% | +9.1% |
| Q2 2015 | $11,230,000 | +81.2% | 793,662 | +36.5% | 0.87% | +70.9% |
| Q1 2015 | $6,199,000 | – | 581,562 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |